HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Matija Hedl Selected Research

Cytokines

10/2021The E3 ubiquitin ligase RNF186 and RNF186 risk variants regulate innate receptor-induced outcomes.
1/2021TNFSF15 Promotes Antimicrobial Pathways in Human Macrophages and These Are Modulated by TNFSF15 Disease-Risk Variants.
6/2017An inflammatory bowel disease-risk variant in INAVA decreases pattern recognition receptor-induced outcomes.
8/2015MTMR3 risk allele enhances innate receptor-induced signaling and cytokines by decreasing autophagy and increasing caspase-1 activation.
7/2015Twist1 and Twist2 Contribute to Cytokine Downregulation following Chronic NOD2 Stimulation of Human Macrophages through the Coordinated Regulation of Transcriptional Repressors and Activators.
2/2015TAM receptor-dependent regulation of SOCS3 and MAPKs contributes to proinflammatory cytokine downregulation following chronic NOD2 stimulation of human macrophages.
6/2014The IL18RAP region disease polymorphism decreases IL-18RAP/IL-18R1/IL-1R1 expression and signaling through innate receptor-initiated pathways.
5/2014Pattern recognition receptor signaling in human dendritic cells is enhanced by ICOS ligand and modulated by the Crohn's disease ICOSLG risk allele.
12/2012Nod2-induced autocrine interleukin-1 alters signaling by ERK and p38 to differentially regulate secretion of inflammatory cytokines.
11/2012IL-22BP is regulated by the inflammasome and modulates tumorigenesis in the intestine.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Matija Hedl Research Topics

Disease

9Crohn Disease (Crohn's Disease)
11/2016 - 08/2004
8Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2021 - 11/2012
5Porcine Reproductive and Respiratory Syndrome (PRRS)
10/2021 - 06/2014
2Ulcerative Colitis
11/2016 - 08/2004
1Weight Loss (Weight Reduction)
01/2021
1Marginal Zone B-Cell Lymphoma (MALT Lymphoma)
01/2021
1Bacterial Infections (Bacterial Infection)
01/2017
1Fibrosarcoma
02/2015
1Leprosy (Hansen's Disease)
09/2014
1Infections
12/2012
1Carcinogenesis
11/2012
1Autoimmune Diseases (Autoimmune Disease)
06/2012
1Inflammation (Inflammations)
01/2011

Drug/Important Bio-Agent (IBA)

11CytokinesIBA
10/2021 - 06/2012
9NucleotidesIBA
01/2017 - 01/2011
8Pattern Recognition ReceptorsIBA
10/2021 - 06/2012
5Proteins (Proteins, Gene)FDA Link
01/2021 - 08/2004
2Interleukin-18 (Interleukin 18)IBA
11/2016 - 06/2014
2Peptidoglycan (Murein)IBA
07/2015 - 02/2015
2Interleukin-10 (Interleukin 10)IBA
02/2015 - 11/2012
2Interleukin-1 (Interleukin 1)IBA
06/2014 - 12/2012
2LigandsIBA
05/2014 - 12/2007
1Ligases (Synthetase)IBA
10/2021
1sodium sulfate (sodium bisulfate)FDA LinkGeneric
01/2021
1Dextrans (Dextran)FDA Link
01/2021
1Protein Kinases (Protein Kinase)IBA
01/2021
1Mitogen-Activated Protein KinasesIBA
01/2021
1TNF Receptor-Associated Factor 2 (TRAF2)IBA
01/2021
1Caspase 8 (Caspase-8)IBA
01/2021
1Janus Kinase InhibitorsIBA
11/2016
1Tumor Necrosis Factor Ligand Superfamily Member 15IBA
09/2014
1Interleukin-22 (IL-22)IBA
11/2012
1InflammasomesIBA
11/2012
1Interleukin-8 (Interleukin 8)IBA
08/2004
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
08/2004

Therapy/Procedure

1Therapeutics
11/2016